Registered number
05371196
Yes Syzygy Limited
Unaudited Filleted Accounts
31 December 2024
Yes Syzygy Limited
Statement of Financial Position
as at 31 December 2024
Notes 2024 2023
£ £
Fixed assets
Intangible assets 4 73,377 73,724
Investments 5 200,200 200,200
273,577 273,924
Current assets
Debtors 6 83,929 86,909
Cash at bank and in hand 657 1,220
84,586 88,129
Creditors: amounts falling due within one year 7 (38,063) (56,276)
Net current assets 46,523 31,853
Net assets 320,100 305,777
Capital and reserves
Called up share capital 200,100 200,100
Revaluation reserve 8 100,000 100,000
Profit and loss account 20,000 5,677
Shareholders' funds 320,100 305,777
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Robert O'Donovan
Director
Approved by the board on 29 September 2025
Company registration number: 05371196
Yes Syzygy Limited
Notes to the Accounts
for the year ended 31 December 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover represents net income from licensing the rights to use its intellectual property, excluding value added tax.
Going Concern
The financial statements have been prepared on a going concern basis. The Directors have prepared forecasts for a period greater than one year from the date of signature of the financial statements and have a reasonable expectation that the company has adequate resources to continue in operation for the foreseeable future.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses.
Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Patents - 10% straight line
Intellectual Property Rights - 20% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Profit before taxation 2024 2023
£ £
Profit before taxation is stated after charging:
Amortisation of intangible assets 14,458 15,316
14,458 15,316
3 Employees 2024 2023
Number Number
Average number of persons employed by the company 0 0
4 Intangible fixed assets £
Patents, Trademarks, Licences and Intellectual Property Rights :
Cost
At 1 January 2024 316,884
Additions 14,111
At 31 December 2024 330,995
Amortisation
At 1 January 2024 243,160
Provided during the year 14,458
At 31 December 2024 257,618
Net book value
At 31 December 2024 73,377
At 31 December 2023 73,724
During 2011 the directors valued the intellectual property rights of the company at £100,000. This valuation has been amortised over ten years, the expected useful life of the asset. The cost of Patents, Trademarks and Licences represents amounts spent to register the company's patents and trademarks in various territories around the world.
5 Investments
Investments in
subsidiary
undertakings
£
Cost
At 1 January 2024 200,200
At 31 December 2024 200,200
The company owns 100% of the issued share capital of The Yes Yes Company Limited, a company incorporated in England and Wales under number 05371471, and Bio-Tech Lubricants Limited, a company incorporated in England and Wales under number 08857325. The directors believe that the value of these investments is not less than cost.
The company indirectly owns 100% of the share capital of Ah! YES Inc, a company incorporated in the state of Delaware, USA, and of Yes Yes Europe Sarl, a company incorporated in France.
6 Debtors 2024 2023
£ £
Amounts owed by group undertakings and undertakings in which the company has a participating interest 83,929 86,909
7 Creditors: amounts falling due within one year 2024 2023
£ £
Trade creditors 6,803 -
Amounts owed to group undertakings and undertakings in which the company has a participating interest 29,410 54,426
Other creditors 1,850 1,850
38,063 56,276
8 Revaluation reserve 2024 2023
£ £
At 1 January 2024 100,000 100,000
At 31 December 2024 100,000 100,000
9 Controlling party
On 4 April 2025 Yes Syzygy Limited was acquired by Project Nazare Limited which is incorporated in England and Wales under number 16358171.
10 Share-based payments
Equity settled
At 31 December 2024, the following share options were outstanding in respect of exit based EMI and unapproved share option plans:
EMI Options
1,325,500 EMI share options were granted during 2016 at a Market Value of £0.01 per Share. During 2019 a further 384,000 EMI share options were granted at a Market Value of £0.01 per share and 399,000 remained outstanding at 31 December 2024 (2023: 474,000). All of these options have vested.
Unapproved Options
300,000 share options were granted during 2016 at a Market Value of £0.01 per share and all remain outstanding at 31 December 2024.
11 Other information
Yes Syzygy Limited is a private company limited by shares and incorporated in England. Its registered office is:
Meadow Barn, Norton Farm
Selborne Road
Alton
Hampshire
GU34 3NB
Yes Syzygy Limited 05371196 false 2024-01-01 2024-12-31 2024-12-31 VT Final Accounts April 2025 Robert O'Donovan No description of principal activity 05371196 2023-01-01 2023-12-31 05371196 core:WithinOneYear 2023-12-31 05371196 core:ShareCapital 2023-12-31 05371196 core:OtherReservesSubtotal 2023-12-31 05371196 core:RetainedEarningsAccumulatedLosses 2023-12-31 05371196 core:RevaluationReserve 2022-12-31 05371196 2024-01-01 2024-12-31 05371196 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05371196 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 05371196 bus:Director40 2024-01-01 2024-12-31 05371196 1 2024-01-01 2024-12-31 05371196 2 2024-01-01 2024-12-31 05371196 core:PatentsTrademarksLicencesConcessionsSimilar 2024-01-01 2024-12-31 05371196 countries:England 2024-01-01 2024-12-31 05371196 bus:FRS102 2024-01-01 2024-12-31 05371196 bus:FilletedAccounts 2024-01-01 2024-12-31 05371196 2024-12-31 05371196 core:WithinOneYear 2024-12-31 05371196 core:ShareCapital 2024-12-31 05371196 core:OtherReservesSubtotal 2024-12-31 05371196 core:RetainedEarningsAccumulatedLosses 2024-12-31 05371196 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-31 05371196 core:RevaluationReserve 2024-12-31 05371196 2023-12-31 05371196 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 05371196 core:RevaluationReserve 2023-12-31 iso4217:GBP xbrli:pure